For the quarter ending 2026-03-31, LONA has $71,590K in assets. $22,287K in debts. $32,833K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 32,833 | 69,276 | ||
| Short-term investments | 34,846 | 19,055 | ||
| Prepaid expenses and other current assets | 1,523 | 1,127 | ||
| Total current assets | 69,202 | 89,458 | ||
| Restricted cash | 631 | 631 | ||
| Property and equipment, at cost | 5,739 | 5,739 | ||
| Less accumulated depreciation | 4,498 | 4,267 | ||
| Property and equipment, net | 1,241 | 1,472 | ||
| Operating lease right-of-use asset | 461 | 535 | ||
| Other long-term assets | 55 | 55 | ||
| Total assets | 71,590 | 92,151 | ||
| Accounts payable | 1,764 | 4,587 | ||
| Accrued liabilities | 4,424 | 4,963 | ||
| Sermonix pre-funded warrant | - | 37,488 | ||
| Current operating lease liability | 478 | 465 | ||
| Total current liabilities | 6,666 | 47,503 | ||
| Operating lease liability, less current portion | 213 | 338 | ||
| Milestone liability | 14,187 | 15,116 | ||
| Other long-term liabilities | 1,221 | 1,404 | ||
| Total liabilities | 22,287 | 64,361 | ||
| Common stock, 0.0001 par value400,000,000 and 90,000,000 shares authorized at march 31,, 2026 and december 31, 2025, respectively 9,393,514 and 9,335,913 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively | 1 | 1 | ||
| Additional paid-in capital | 594,018 | 539,548 | ||
| Accumulated other comprehensive (loss) income | -13 | -4 | ||
| Accumulated deficit | -544,703 | -511,755 | ||
| Total stockholders' equity | 49,303 | 27,790 | ||
| Total liabilities and stockholders' equity | 71,590 | 92,151 | ||
LeonaBio, Inc. (LONA)
LeonaBio, Inc. (LONA)